| 前收市價 | 90.15 |
| 開市 | 90.21 |
| 買盤 | 89.84 x 0 |
| 賣出價 | 90.26 x 0 |
| 今日波幅 | 89.99 - 90.21 |
| 52 週波幅 | 80.89 - 104.24 |
| 成交量 | |
| 平均成交量 | 1,124 |
| 市值 | 112.58B |
| Beta 值 (5 年，每月) | 0.42 |
| 市盈率 (最近 12 個月) | 24.93 |
| 每股盈利 (最近 12 個月) | 3.61 |
| 業績公佈日 | 2024年7月25日 |
| 遠期股息及收益率 | 3.76 (4.17%) |
| 除息日 | 2024年5月13日 |
| 1 年預測目標價 | 無 |
BloombergSanofi Seeks Initial Offers for Its $20 Billion Consumer Arm
(Bloomberg) -- Sanofi SA has called for initial bids for its $20 billion consumer health division, as the French pharmaceutical giant simultaneously moves forward with preparations for a possible listing of the business, according to people familiar with the matter. Most Read from BloombergYouTuber Dr Disrespect Was Allegedly Kicked Off Twitch for Messaging MinorTrump Could Actually Lose Florida. Here’s Why.Volkswagen Invests $5 Billion in EV Startup Rivian to Form Joint VentureNvidia Rout Takes
ZacksNovavax (NVAX) Seeks Nod for Updated COVID-19 Jab in Europe
Novavax (NVAX) seeks marketing authorization in the European Union for an updated version of its COVID-19 vaccine, which has been formulated to target the JN.1 variant.
FortuneThe secrets of success with Paul Hudson, CEO of Sanofi, the leader who’s channeling AI to find the next pharma wonder drug
Today we meet with British CEO Paul Hudson to find out how he plans to build the Sanofi of tomorrow.
